WALTHAM, Mass. and BOULDER, Colo., June 11, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically ...

Cogent Biosciences, a biotechnology company specializing in precision therapies, has secured a debt financing facility of up to $400 million with SLR Capital Partners to support its growth and the ...

Cogent Biosciences, Inc. announced strong preclinical data from four of its therapeutic pipeline programs during the AACR 2025 Annual Meeting in Chicago, showcasing its work on precision therapies ...

In this article, we are going to take a look at where Cogent Biosciences, Inc. (NASDAQ:COGT) stands against other best low priced biotech stocks to buy now. On May 8, Michael Yee, Senior Biotech ...

Cogent Biosciences has a one year low of $5.30 and a one year high of $12.61. Institutional Investors Weigh In On Cogent Biosciences Large investors have recently added to or reduced their stakes ...

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically ...